Commonwealth Parliamentary Association

Lord Kakkar Excerpts

Thursday 8th September 2011 Lords Chamber

[Lord Kakkar]

My Lords, I join noble Lords in congratulating the noble Baroness, Lady Hooper, on having secured this important debate. I wish to confine my comments to the continuing role of the Commonwealth, particularly with regard to healthcare and biomedical research. In so doing, I remind noble Lords of my declarations of interest, particularly my role as Professor of Surgery at University College London.

There is a distinguished heritage with regard to health and the provision of postgraduate medical education and training associated with the Commonwealth. For many decades, medical trainees, graduates and other healthcare professionals from Commonwealth countries have come to our country and made a vital contribution to the establishment of the National Health Service and ensured that that service was sustained over many years. Many of them returned to their own Commonwealth countries, having benefited from training in the United Kingdom, and went on to become leaders of disciplines in the profession of medicine in their own countries, contributing to the development of healthcare systems in many nations based on the provision of healthcare in the United Kingdom. In so doing, they brought great credit to our country and increased the influence of the United Kingdom in those countries because the provision of healthcare is so very important in every nation.

Equally, our own trainees had the opportunity to practise in many Commonwealth countries, making important contributions, learning an awful lot and having their own careers enriched as a result. The contributions in this two-way relationship have been substantial. In our own country the development of primary care, acute hospital practice, mental health and biomedical research have been hugely enriched by the relationships between Commonwealth countries. However, in the past 10 to 15 years, that emphasis on encouraging links with regard to healthcare and biomedical research across Commonwealth countries has become somewhat less important to our nation as we have looked to other regions to deal with the provision of staff and medical professionals to help in the delivery of healthcare in the United Kingdom. That is a great pity because one of the important by-products of these close links in healthcare and biomedical research has been the promotion of our own healthcare and biopharmaceutical industry in Commonwealth countries. We often hear that this area of economic activity and endeavour in health and biomedicine is the second most important industry for our nation after financial services in terms of its economic value.

Moving forward, there are important opportunities for us to refocus on the Commonwealth. As we have heard, one-third of the world’s population are citizens of Commonwealth countries. Many of these nations are seeing substantial economic development. As nations develop there is increasing emphasis on the provision of healthcare and the training of healthcare professionals. Our universities, National Health Service, healthcare industries and biopharmaceutical industry could all benefit from a renewed focus on the opportunities available if there were greater collaboration and co-operation in healthcare provision across Commonwealth nations. Equally, those nations could benefit from the very fine industries, knowledge, technology and innovation that we have developing in our own country in our universities and their associated industries.

I have four questions for the Minister with regard to health and training of healthcare professionals in relation to the Commonwealth. First, do Her Majesty’s Government have a specific strategy for ensuring that we can once again encourage some of the most able and capable medical trainees from Commonwealth countries to spend some of their postgraduate training time here in the United Kingdom rather than go to other countries, such as the United States, or other European countries? Secondly, can we facilitate our own trainees to take advantage of the wonderful opportunities existing in Commonwealth countries to enrich their own careers and training opportunities? Thirdly, is there a specific strategy to promote our healthcare and biopharmaceutical industries in Commonwealth countries, so that they can improve and increase their export opportunities and in so doing, ensure that the innovation and discovery from our own universities, and within those industries, can be used to improve healthcare delivery and health in Commonwealth countries? Fourthly, and finally, might there be opportunities for us to build on the concept of Commonwealth learning to develop a virtual Commonwealth postgraduate medical federation or university to promote continuing medical education driven from the United Kingdom to assist the development of healthcare in Commonwealth countries?